Global Epidemiology of HIV Infection and Related Syndemics Affecting Transgender People

Overview

Journal J Acquir Immune Defic Syndr

Specialty Infectious Diseases

Date 2016 Jul 19

PMID 27429185

Citations 214

Authors

Tonia Poteat

Ayden Scheim

Jessica Xavier

Sari Reisner

Stefan Baral

Affiliations

Soon will be listed here.

Abstract

Introduction: Transgender populations have been underrepresented in HIV epidemiologic studies and consequently in HIV prevention, care, and treatment programs. Since 2012, there has been a dramatic increase in research focused on transgender people. Studies highlight the burden of HIV and risk determinants, including intersecting stigmas, as drivers of syndemics among transgender populations. This review synthesizes the most recent global epidemiology of HIV infection and describes current gaps in research and interventions to inform prioritization of HIV research for transgender populations.

Methods: A systematic review was conducted of the medical literature published between January 1, 2012 and November 30, 2015. The data focused on HIV prevalence, determinants of risk, and syndemics among transgender populations.

Results: Estimates varied dramatically by location and subpopulation. Transfeminine individuals have some of the highest concentrated HIV epidemics in the world with laboratory-confirmed prevalence up to 40%. Data were sparse among trans masculine individuals; however, they suggest potential increased risk for trans masculine men who have sex with men (MSM). No prevalence data were available for transgender people across Sub-Saharan Africa or Eastern Europe/Central Asia. Emerging data consistently support the association of syndemic conditions with HIV risk in transgender populations.

Discussion: Addressing syndemic conditions and gender-specific challenges is critical to ensure engagement and retention in HIV prevention by transgender populations. Future research should prioritize: filling knowledge gaps in HIV epidemiology; elucidating how stigma shapes syndemic factors to produce HIV and other deleterious effects on transgender health; and understanding how to effectively implement HIV interventions for transgender people.

Citing Articles

A Systematic Review and Meta-Analysis of HIV/AIDS Prevalence Among Transgender Populations Worldwide.

Moradi G, Soheili M, Bahrami P, Amini E, Rashti R, Azadnia A Health Sci Rep. 2025; 8(3):e70500.

PMID: 40041791 PMC: 11872686. DOI: 10.1002/hsr2.70500.

Understanding harms associated with gender identity conversion efforts among transgender and nonbinary individuals: The role of preexisting mental well-being.

Mammadli T, Call J, Whitfield D, Holloway B, Walls N Int J Transgend Health. 2025; 26(1):157-179.

PMID: 39981281 PMC: 11837913. DOI: 10.1080/26895269.2024.2333531.

HIV prevention among adolescents travestis and transgender women in three Brazilian capitals, 2019-2023.

Leite B, Magno L, Greco D, Grangeiro A, Dourado I Epidemiol Serv Saude. 2025; 33(spe1):e2024321.

PMID: 39813451 PMC: 11734661. DOI: 10.1590/S2237-96222024v33e2024321.especial.en.

Review protocol for a systematic review and meta-analysis on HIV inequities in transgender and non-binary populations.

Lucas R, Moodley R, Garcia Gutierrez J, Bambilla A, Singh D, Rogers H BMJ Open. 2025; 15(1):e087821.

PMID: 39773796 PMC: 11749687. DOI: 10.1136/bmjopen-2024-087821.

Adaptation of a HIV Prevention Mobile App for Transmasculine People: A Pilot Acceptability and Feasibility Study.

Jones J, Butler G, Woody M, Sheets M, Castel A, Kulie P Transgend Health. 2024; 9(6):573-581.

PMID: 39735378 PMC: 11669636. DOI: 10.1089/trgh.2023.0041.

References

Pinheiro Junior F, Kendall C, Martins T, Mota R, Macena R, Glick J . Risk factors associated with resistance to HIV testing among transwomen in Brazil. AIDS Care. 2015; 28(1):92-7. DOI: 10.1080/09540121.2015.1066751. View

Reisner S, Gamarel K, Nemoto T, Operario D . Dyadic effects of gender minority stressors in substance use behaviors among transgender women and their non-transgender male partners. Psychol Sex Orientat Gend Divers. 2015; 1(1):63-71. PMC: 4311402. DOI: 10.1037/0000013. View

Socias M, Marshall B, Aristegui I, Romero M, Cahn P, Kerr T . Factors associated with healthcare avoidance among transgender women in Argentina. Int J Equity Health. 2014; 13(1):81. PMC: 4220051. DOI: 10.1186/s12939-014-0081-7. View

Benotsch E, Zimmerman R, Cathers L, McNulty S, Pierce J, Heck T . Non-medical use of prescription drugs, polysubstance use, and mental health in transgender adults. Drug Alcohol Depend. 2013; 132(1-2):391-4. DOI: 10.1016/j.drugalcdep.2013.02.027. View

de Lind van Wijngaarden J, Schunter B, Iqbal Q . Sexual abuse, social stigma and HIV vulnerability among young feminised men in Lahore and Karachi, Pakistan. Cult Health Sex. 2012; 15(1):73-84. DOI: 10.1080/13691058.2012.743186. View

Costa A, Fontanari A, Jacinto M, Cardoso da Silva D, Lorencetti E, da Rosa Filho H . Population-based HIV prevalence and associated factors in male-to-female transsexuals from Southern Brazil. Arch Sex Behav. 2014; 44(2):521-4. DOI: 10.1007/s10508-014-0386-z. View

Reisner S, White J, Mayer K, Mimiaga M . Sexual risk behaviors and psychosocial health concerns of female-to-male transgender men screening for STDs at an urban community health center. AIDS Care. 2013; 26(7):857-64. PMC: 4634528. DOI: 10.1080/09540121.2013.855701. View

Lipsitz M, Segura E, Castro J, Smith E, Medrano C, Clark J . Bringing testing to the people - benefits of mobile unit HIV/syphilis testing in Lima, Peru, 2007-2009. Int J STD AIDS. 2013; 25(5):325-31. PMC: 4110635. DOI: 10.1177/0956462413507443. View

Habarta N, Wang G, Mulatu M, Larish N . HIV Testing by Transgender Status at Centers for Disease Control and Prevention-Funded Sites in the United States, Puerto Rico, and US Virgin Islands, 2009-2011. Am J Public Health. 2015; 105(9):1917-25. PMC: 4539831. DOI: 10.2105/AJPH.2015.302659. View

10.

De Santis J . HIV infection risk factors among male-to-female transgender persons: a review of the literature. J Assoc Nurses AIDS Care. 2009; 20(5):362-72. DOI: 10.1016/j.jana.2009.06.005. View

11.

Fernandez-Balbuena S, Belza M, Urdaneta E, Esteso R, Rosales-Statkus M, de La Fuente L . Serving the underserved: an HIV testing program for populations reluctant to attend conventional settings. Int J Public Health. 2014; 60(1):121-6. DOI: 10.1007/s00038-014-0606-2. View

12.

Operario D, Nemoto T, Iwamoto M, Moore T . Risk for HIV and unprotected sexual behavior in male primary partners of transgender women. Arch Sex Behav. 2011; 40(6):1255-61. DOI: 10.1007/s10508-011-9781-x. View

13.

Carobene M, Bolcic F, Farias M, Quarleri J, Avila M . HIV, HBV, and HCV molecular epidemiology among trans (transvestites, transsexuals, and transgender) sex workers in Argentina. J Med Virol. 2013; 86(1):64-70. DOI: 10.1002/jmv.23805. View

14.

Wilson E, Chen Y, Arayasirikul S, Wenzel C, Raymond H . Connecting the dots: examining transgender women's utilization of transition-related medical care and associations with mental health, substance use, and HIV. J Urban Health. 2014; 92(1):182-92. PMC: 4338120. DOI: 10.1007/s11524-014-9921-4. View

15.

Feldman J, Swinburne Romine R, Bockting W . HIV risk behaviors in the U.S. transgender population: prevalence and predictors in a large internet sample. J Homosex. 2014; 61(11):1558-88. PMC: 4162812. DOI: 10.1080/00918369.2014.944048. View

16.

Sevelius J, Keatley J, Calma N, Arnold E . 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016; 11(7-8):1060-75. PMC: 10204128. DOI: 10.1080/17441692.2016.1154085. View

17.

Clark T, Lucassen M, Bullen P, Denny S, Fleming T, Robinson E . The health and well-being of transgender high school students: results from the New Zealand adolescent health survey (Youth'12). J Adolesc Health. 2014; 55(1):93-9. DOI: 10.1016/j.jadohealth.2013.11.008. View

18.

Poteat T, German D, Flynn C . The conflation of gender and sex: Gaps and opportunities in HIV data among transgender women and MSM. Glob Public Health. 2016; 11(7-8):835-48. PMC: 4957661. DOI: 10.1080/17441692.2015.1134615. View

19.

Buchbinder S, Glidden D, Liu A, McMahan V, Guanira J, Mayer K . HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial. Lancet Infect Dis. 2014; 14(6):468-75. PMC: 4133171. DOI: 10.1016/S1473-3099(14)70025-8. View

20.

Peitzmeier S, Reisner S, Harigopal P, Potter J . Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening. J Gen Intern Med. 2014; 29(5):778-84. PMC: 4000345. DOI: 10.1007/s11606-013-2753-1. View